Evaluation of the quality of life of gynecological cancer patients submitted to antineoplastic chemotherapy.
This study aimed to evaluate the quality of life of female gynecological cancer patients submitted to antineoplastic chemotherapy Between August 2007 and April 2009, 50 patients who were undergoing chemotherapy at an outpatient chemotherapy unit in Uberaba-MG were interviewed, by applying the instrument of evaluation of Quality of Life of the World Health Organization, WHOQOL-BREF. The results showed that the domain most affected was the Physical and the more preserved, the Social, with the mean of the general quality of life above the means obtained in other studies. All domains correlated significantly with the general quality of life. It was evident then that the quality of life of these women is satisfactory, however it is suggested that the domains with lower scores be the targets of more accurate observations during multi-professional interventions in order to provide a better quality of life during the chemotherapy treatment.
Universidade Federal do Triângulo Mineiro, Centro de Graduação em Enfermagem, Departamento de Enfermagem na Área Hospitalar, Uberaba, MG, Brazil.
Lívia Loamí Ruyz
LL
Jorge
Sueli Riul
SR
da Silva
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001938:Brazil; D001943:Breast Neoplasms / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D003625:Data Collection; D003627:Data Interpretation, Statistical; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000453:epidemiology / Q000451:nursing*; D006304:Health Status; D006801:Humans; D008875:Middle Aged; D009859:Oncology Nursing; D017060:Patient Satisfaction; D015995:Prevalence; D011788:Quality of Life / Q000523:psychology; D011795:Surveys and Questionnaires; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology; D014944:World Health Organization
D000970:Antineoplastic Agents